AMP Stock Analysis: Ameriprise Financial | NYSE
Asset Management | NYSE, USA | Market Cap: 50.309m USD | 12M Return: 11.4% | US03076C1062 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 236M
EPS Trend: 99.0%
Qual. Beats: 0
Rev. Trend: 98.9%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Ameriprise Financial (AMP) is a large-cap U.S. diversified financial services company headquartered in Minneapolis, founded in 1894 and spun off as an independent public company in 2005 after previously operating as American Express Financial Corporation. It serves individual and institutional clients across the U.S. and internationally through four segments: Advice & Wealth Management (financial planning, brokerage, advisory accounts, mutual funds, insurance, annuities, and banking products); Asset Management (operated under the Columbia Threadneedle Investments brand, offering mutual funds, ETFs, separately managed accounts, hedge funds, and property/infrastructure funds); Retirement & Protection Solutions (variable annuities, life insurance, and disability income insurance); and Corporate & Other. The firm generates revenue from a mix of fee-based sources-including advisory and asset management fees tied to assets under management-along with insurance premiums and distribution income, a structure typical of diversified wealth and asset managers. It is classified within the GICS Asset Management & Custody Banks sub-industry.
- Columbia Threadneedle AUM climbs on equity market gains and net inflows
- Interest rate shifts impact variable annuity spreads and crediting rates
- Capital return accelerates via aggressive share buybacks and dividends
| Net Income: 3.95b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA -0.24 > 1.0 |
| NWC/Revenue: 117.0% < 20% (prev 331.5%; Δ -214.5% < -1%) |
| CFO/TA 0.01 > 3% & CFO 2.79b > Net Income 3.95b |
| Net Debt (-3.71b) to EBITDA (4.74b): -0.78 < 3 |
| Current Ratio: 8.48 > 1.5 & < 3 |
| Outstanding Shares: last quarter (92.9m) vs 12m ago -5.97% < -2% |
| Gross Margin: 50.24% > 18% (prev 98.15%; Δ -47.91% > 0.5%) |
| Asset Turnover: 10.36% > 50% (prev 9.53%; Δ 0.82% > 0%) |
| Interest Coverage Ratio: 14.33 > 6 (EBIT TTM 4.70b / Interest Expense TTM 328.0m) |
| A: 0.12 (Total Current Assets 26.3b - Total Current Liabilities 3.10b) / Total Assets 198b |
| B: 0.15 (Retained Earnings 29.4b / Total Assets 198b) |
| C: 0.02 (EBIT TTM 4.70b / Avg Total Assets 191b) |
| D: 0.03 (Book Value of Equity 6.37b / Total Liabilities 192b) |
| Altman-Z'' = 1.45 = BB |
| DSRI: 0.97 (Receivables 16.0b/14.7b, Revenue 19.8b/17.6b) |
| GMI: 1.95 (GM 98.15% / 50.24%) |
| AQI: 1.30 (AQ_t 0.86 / AQ_t-1 0.66) |
| SGI: 1.12 (Revenue 19.8b / 17.6b) |
| TATA: 0.01 (NI 3.95b - CFO 2.79b) / TA 198b) |
| Beneish M = -1.92 (Cap -4..+1) = B |
As of August 23, 2026, the stock is trading at USD 555.59 with a total of 571,522 shares traded. Over the past week, the price has changed by -2.45%, over one month by +5.48%, over three months by +23.69% and over the past year by +11.43%.
Current recommended Stop Loss: 535.80 (which is 3.6% or 1.7 ATR below the current price).
Ameriprise Financial has received a consensus analysts rating of 3.77. Therefore, it is recommended to hold AMP.
- StrongBuy: 5
- Buy: 1
- Hold: 6
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 574.4 | 3.4% |
P/E Trailing = 13.7537
P/E Forward = 12.5945
P/S = 2.5359
P/B = 7.9028
P/EG = 1.8253
Revenue TTM = 19.8b USD
EBIT TTM = 4.70b USD
EBITDA TTM = 4.74b USD
Long Term Debt = 6.33b USD (from longTermDebt, last quarter)
Short Term Debt = 200.0m USD (from shortTermDebt, last quarter)
Debt = 6.53b USD (from shortLongTermDebtTotal, last quarter) + Leases 1.00m
Net Debt = -3.71b USD (calculated: Debt 6.53b - CCE 10.2b)
Enterprise Value = 46.6b USD (50.3b + Debt 6.53b - CCE 10.2b)
Interest Coverage Ratio = 14.33 (Ebit TTM 4.70b / Interest Expense TTM 328.0m)
EV/FCF = 16.29x (Enterprise Value 46.6b / FCF TTM 2.86b)
FCF Yield = 6.14% (FCF TTM 2.86b / Enterprise Value 46.6b)
FCF Margin = 14.43% (FCF TTM 2.86b / Revenue TTM 19.8b)
Net Margin = 19.92% (Net Income TTM 3.95b / Revenue TTM 19.8b)
Gross Margin = 50.24% ((Revenue TTM 19.8b - Cost of Revenue TTM 9.86b) / Revenue TTM)
Gross Margin QoQ = 44.66% (prev 50.31%)
Tobins Q-Ratio = 0.24 (Enterprise Value 46.6b / Total Assets 198b)
Interest Expense / Debt = 5.02% (Interest Expense 328.0m / Debt 6.53b)
Taxrate = 21.85% (1.10b / 5.05b)
NOPAT = 3.67b (EBIT 4.70b * (1 - 21.85%))
Current Ratio = 4.38 (Total Current Assets 26.3b / Total Current Liabilities 5.99b)
Debt / Equity = 1.03 (Debt 6.53b / totalStockholderEquity, last quarter 6.37b)
Debt / EBITDA = -0.78 (Net Debt -3.71b / EBITDA 4.74b)
Debt / FCF = -1.30 (Net Debt -3.71b / FCF TTM 2.86b)
Total Stockholder Equity = 6.40b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.06% (Net Income 3.95b / Total Assets 198b)
RoE = 61.73% (Net Income TTM 3.95b / Total Stockholder Equity 6.40b)
RoCE = 36.94% (EBIT 4.70b / Capital Employed (Equity 6.40b + L.T.Debt 6.33b))
RoIC = 1.89% (NOPAT 3.67b / Invested Capital 194b)
WACC = 8.61% (E(50.3b)/V(56.8b) * Re(9.22%) + D(6.53b)/V(56.8b) * Rd(5.02%) * (1-Tc(0.22)))
Discount Rate = 9.22% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -98.93 | Cagr: -4.65%
[DCF] Terminal Value 73.29% ; FCFF base≈2.96b ; Y1≈2.77b ; Y5≈2.54b
[DCF] Fair Price = 477.4 (EV 38.5b - Net Debt -3.71b = Equity 42.2b / Shares 88.3m; r=8.61% [WACC]; 5y FCF grow -8.27% → 2.50% )
EPS Correlation: 99.03 | EPS CAGR: 15.67% | SUE: 0.45 | # QB: 0
Revenue Correlation: 98.91 | Revenue CAGR: 8.13% | SUE: 0.66 | # QB: 0
EPS current Quarter (2026-09-30): EPS=11.78 | Chg30d=+4.40% | Revisions=+75% | Analysts=12
EPS current Year (2026-12-31): EPS=46.39 | Chg30d=+3.04% | Revisions=+80% | GrowthEPS=+18.1% | GrowthRev=+9.4%
EPS next Year (2027-12-31): EPS=51.54 | Chg30d=+4.41% | Revisions=+81% | GrowthEPS=+11.1% | GrowthRev=+5.9%
[Analyst] Revisions Ratio: +92% (up=34, down=0)